pubmed-article:18489610 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18489610 | lifeskim:mentions | umls-concept:C0014544 | lld:lifeskim |
pubmed-article:18489610 | lifeskim:mentions | umls-concept:C1419856 | lld:lifeskim |
pubmed-article:18489610 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:18489610 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:18489610 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18489610 | pubmed:dateCreated | 2008-8-22 | lld:pubmed |
pubmed-article:18489610 | pubmed:abstractText | To establish whether the SCN1A IVS5-91 G > A polymorphism of the SCN1A gene, which encodes the neuronal sodium channel alpha subunit, affects responsiveness to the antiepileptic drugs (AEDS) carbamazepine and/or phenytoin. | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:language | eng | lld:pubmed |
pubmed-article:18489610 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18489610 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18489610 | pubmed:month | Aug | lld:pubmed |
pubmed-article:18489610 | pubmed:issn | 1365-2125 | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:NakagawaKazuk... | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:HoriMasaharuM | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:NakagawaTakeh... | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:SeoTakayukiT | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:IshitsuTakate... | lld:pubmed |
pubmed-article:18489610 | pubmed:author | pubmed-author:AbeTomohideT | lld:pubmed |
pubmed-article:18489610 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18489610 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:18489610 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18489610 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18489610 | pubmed:pagination | 304-7 | lld:pubmed |
pubmed-article:18489610 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:meshHeading | pubmed-meshheading:18489610... | lld:pubmed |
pubmed-article:18489610 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18489610 | pubmed:articleTitle | Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. | lld:pubmed |
pubmed-article:18489610 | pubmed:affiliation | Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Science, Kumamoto University, Kumamoto, Japan. | lld:pubmed |
pubmed-article:18489610 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18489610 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:6323 | entrezgene:pubmed | pubmed-article:18489610 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18489610 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18489610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18489610 | lld:pubmed |